India's first intranasal corona vaccine approved for emergency use, developed by Bharat Biotech

The DCGI (Drugs Controller General of India) on Tuesday approved Bharat Biotech's intranasal corona vaccine for emergency use. The Drugs Controller General of India (DCGI) on Tuesday allowed Bharat Biotech's intranasal corona vaccine for emergency use for those above 18 years of age. BBV154 is India's first nasal vaccine.

Union Health Minister Mansukh Mandaviya gave this information by tweeting. He wrote 'India's war against Covid-19 got strength! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) Nasal Vaccine has been permitted for emergency restricted use for persons above 18 years of age.

The Health Minister said, 'This step will further strengthen our war against the epidemic. In the war against the Corona epidemic under the leadership of Prime Minister Narendra Modi, India has done its science, research and research (R).

According to Bharat Biotech, the company developing the vaccine, we will also be able to take this nasal vaccine as a booster dose. When this vaccine was approved for Phase III trials, it was only then that it was told that this intranasal vaccine would be administered in an interval of 28 days.